A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.
Public ClinicalTrials.gov record NCT02425826. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Multicenter, Randomized, Placebo-controlled, Double-blind, Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the clinical efficacy, the patients quality of life, and safety of oral apremilast 30 mg twice daily (BID) compared to placebo, in adult patients with moderate plaque psoriasis during the 16 week Placebo controlled Phase and then upto 1 year in the Extension Phase of the trial.
Study identification
- NCT ID
- NCT02425826
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 221 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 20, 2015 (Actual)
- Primary completion
- Feb 12, 2016 (Actual)
- Completion
- Nov 22, 2016 (Actual)
- Last update posted
- Jun 5, 2023
2015 – 2016
United States locations
- U.S. sites
- 26
- U.S. states
- 16
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB at Birmingham - The Kirklin Clinic | Birmingham | Alabama | 35233 | — |
| Center For Dermatology | Fremont | California | 94538 | — |
| Dermatology Research Associates | Los Angeles | California | 90045 | — |
| Blue Harbor Dermatology | Newport Beach | California | 92663 | — |
| Center for Dermatology and Laser Surgery | Sacramento | California | 95819 | — |
| East Bay Rheumatology Medical | San Leandro | California | 94578 | — |
| Tien Q. Nguyen MD Inc | Tustin | California | 92780 | — |
| UConn Health Center | Farmington | Connecticut | 06030 | — |
| Dermatology Associates | Panama City | Florida | 32405-4542 | — |
| USF Health Faculty Office Building-FOB | Tampa | Florida | 33612 | — |
| Forward Clinical Trials Inc | Tampa | Florida | 33624 | — |
| Dermatologic Surgery Specialists, P.C. | Macon | Georgia | 31217 | — |
| Shideler Clinical Research Center | Carmel | Indiana | 46032 | — |
| Dermatology Specialists, PSC | Louisville | Kentucky | 40202 | — |
| DermResearch, PLLC | Louisville | Kentucky | 40217 | — |
| Lawrence Green, MD, LLC | Rockville | Maryland | 20850 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Las Vegas Skin and Cancer Clinics | Las Vegas | Nevada | 89052 | — |
| Psoriasis Treatment Center of Central New Jersey | East Windsor | New Jersey | 08520 | — |
| Garden City Dermatology | Garden City | New York | 11530 | — |
| Sadick Research Group | New York | New York | 10075 | — |
| Dermatology Associates of Rochester PC | Rochester | New York | 14623 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267-0501 | — |
| Dermatology and Laser Center of Charleston | Charleston | South Carolina | 29414 | — |
| University of Utah School of Medicine | Salt Lake City | Utah | 84132 | — |
| Dermatology Consultants, Inc. | Lynchburg | Virginia | 24501 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02425826, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 5, 2023 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02425826 live on ClinicalTrials.gov.